Aquestive director granted 50,500 stock options
Aquestive Therapeutics director Abigail L. Jenkins received an equity award of non-qualified stock options for 50,500 shares of common stock.
Rhea-AI Filing Summary
Aquestive Therapeutics director Abigail L. Jenkins received an equity award of non-qualified stock options for 50,500 shares of common stock. The options have an exercise price of $3.99 per share, expire on June 10, 2036, and represent her direct holdings of this option grant.
All 50,500 underlying shares vest on June 10, 2027, provided she remains in continuous service with the company through that date. This is a compensation-related grant, not an open-market purchase or sale, so it mainly updates her potential future ownership rather than reflecting a trading decision.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 50,500 shares
Grant/Award
1 txn
Insider
Jenkins Abigail L.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualified Stock Option (right to buy) | 50,500 | $0.00 | $0.00 |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 50,500 contracts (Direct)
Footnotes (1)
- F1. The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Ms. Jenkins' continuous service with the Issuer from the grant date through the applicable vesting date.
Key Figures
Option grant size: 50,500 options
Exercise price: $3.99 per share
Vesting date: June 10, 2027
+3 more
6 metrics
Option grant size
50,500 options
Non-qualified stock option award to Abigail L. Jenkins
Exercise price
$3.99 per share
Strike price for the non-qualified stock options
Vesting date
June 10, 2027
100% of underlying shares vest on this date
Expiration date
June 10, 2036
Date the options expire if not exercised
Underlying shares
50,500 shares
Common stock underlying the option grant
Post-transaction option holdings
50,500 options
Total options held for this award after the transaction
Key Terms
Non-Qualified Stock Option (right to buy), vest, exercise price, expiration date, +1 more
5 terms
Non-Qualified Stock Option (right to buy) financial
"security_title: Non-Qualified Stock Option (right to buy)"
vest financial
"100% of the underlying shares vest June 10, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price: 3.9900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-10T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Abigail L. Jenkins report in this Aquestive Therapeutics (AQST) Form 4?
Abigail L. Jenkins reported receiving a grant of 50,500 non-qualified stock options. These options give her the right to buy Aquestive Therapeutics common stock at $3.99 per share, subject to vesting and an expiration date in 2036.
How many Aquestive Therapeutics (AQST) options were granted to Abigail Jenkins and at what price?
She was granted 50,500 non-qualified stock options with an exercise price of $3.99 per share. This price is the amount she would pay per share if she chooses to exercise the options after they vest.
When do Abigail Jenkins' Aquestive Therapeutics (AQST) stock options vest?
All 50,500 underlying shares vest on June 10, 2027. Vesting is contingent on Ms. Jenkins maintaining continuous service with Aquestive Therapeutics from the grant date through that vesting date, according to the disclosed footnote.
When do Abigail Jenkins' Aquestive Therapeutics (AQST) options expire?
The non-qualified stock options expire on June 10, 2036. If the options are not exercised by that expiration date, the right to buy 50,500 shares at $3.99 per share will lapse and become worthless.
Is Abigail Jenkins buying or selling Aquestive Therapeutics (AQST) stock in this Form 4?
She is not buying or selling shares in the market; she is receiving an option grant. The Form 4 reports a compensation-related award of 50,500 non-qualified stock options, rather than an open-market purchase or sale of common stock.
How many Aquestive Therapeutics (AQST) options does Abigail Jenkins hold after this transaction?
After this grant, she holds 50,500 non-qualified stock options as reported for this award. The filing shows this total for the granted option position, with no additional derivative holdings listed in the derivative summary section.
AI-generated analysis. How Rhea-AI works. Not financial advice.
